To discuss the implications of the Framingham risk score (FRS) in predicting cardiovascular disease (CVD) and its novel association with cancer risk.
Key Findings:
Individuals in the highest FRS tertile had over two-fold increased cancer risk and up to ten-fold higher risk of heart failure, highlighting the novel association with cancer.
The association with incident cancer is novel and enhances the prognostic utility of the FRS.
CVD and cancer share common risk factors and pathogenic pathways, including inflammation.
Interpretation:
The FRS serves as a broader metric of global vulnerability, predicting both cardiovascular and cancer risks, suggesting a need for integrated disease risk assessment strategies.
Limitations:
The study is observational and post hoc, limiting causal inference and introducing potential biases.
Inclusion of cancer as a composite endpoint without specific site analysis may affect generalizability.
The PREVEND cohort is enriched for microalbuminuria, which may limit external applicability.
Conclusion:
The FRS can be used as a population-level screening tool for identifying individuals at elevated risk of both cardiovascular disease and cancer, advocating for integrated preventive strategies such as lifestyle modifications and regular screenings.
